Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial
Journal of Nephropharmacology · 2017
DOI: 10.15171/npj.2017.25 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Nephropharmacology, 2017. Verfasst von Hosein Chiti und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chiti, H., Manjili, M. H., Pezeshgi, A., Mousavinasab, S., Abbaspour, Z., & Asadi-Khiavi, M. (2017). Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial. Journal of Nephropharmacology. https://doi.org/10.15171/npj.2017.25
Vancouver
Chiti H, Manjili MH, Pezeshgi A, Mousavinasab S, Abbaspour Z, Asadi-Khiavi M. Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial. Journal of Nephropharmacology. 2017. doi:10.15171/npj.2017.25
BibTeX
@article{Chiti2017,
author = {Chiti, Hosein and Manjili, Maryam Hajipour and Pezeshgi, Aiyoub and Mousavinasab, Seyednouraddin and Abbaspour, Zahra and Asadi-Khiavi, Masoud},
title = {Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial},
journal = {Journal of Nephropharmacology},
year = {2017},
doi = {10.15171/npj.2017.25}
}
EUVIMED